GlobeNewswire

Kevin Gaskell, Acclaimed CEO, to Deliver Keynote at ConnectWise IT Nation Europe

Dela

Conference Registration Deadline Quickly Approaching for Companies that Sell, Service and Support Technology

 

LONDON, March 26, 2018 (GLOBE NEWSWIRE) -- Now is the time for technology professionals to beat the registration deadline for IT Nation Europe, an annual ConnectWise conference that provides three days of education, networking and collaboration for technology team members. This year's event takes place 18-20 April.

Kevin Gaskell, serial entrepreneur and former CEO of multiple companies, including Porsche, BMW and Lamborghini, will be the guest keynote speaker. He has founded companies large and small - the smallest has four employees, the largest over 600 - and is the author of Inspired Leadership: How You Can Achieve Extraordinary Results in Business.

Gaskell said his IT Nation Europe keynote will draw on his 25 years of experience building and managing companies, and will provide audience members practical advice, tools and processes that they can begin to use the following day to inspire their teams to build world-class businesses.

"The goal is not to build big companies but to build great companies," he said.

ConnectWise CEO Arnie Bellini, who will kick off the conference with the opening keynote on 19 April, said this year's event will have something for all technology teams, no matter the size of their businesses.

"Our inaugural IT Nation Europe conference last year received such amazing feedback from the 300 plus attendees that we've upped the ante this year to bring our partners, prospects and vendors an even more robust agenda," Bellini said. "I am confident that no matter your role in the ecosystem, you'll find these three days of collaboration, networking and education well worth your time as they help you move closer to achieving your business goals."

Included among the many speakers scheduled for IT Nation Europe speakers are Craig Fulton, Chief Product Officer for ConnectWise; Brad Schow, Vice President for HTG Peer Groups; John Whitty, CEO, Solar Communications; and Nigel Houlden, Head of the Technology Policy, Information Commissioner's Office (ICO), who will discuss the GDPR, what type of data falls under the scope, and technology solution provider responsibilities.

In addition to the two keynotes and the much-anticipated GDPR enforcement discussion with ICO's Houlden, conference attendees will have access to:    

  • More than 10 hours of dedicated ConnectWise product training;
  • 50 breakout sessions with speakers representing top MSPs, industry thought leaders and ConnectWise product experts;
  • Multiple networking opportunities with other IT solution providers, ConnectWise colleagues and industry vendors;
  • And an inaugural gala during which ConnectWise will announce winners for Partner of the Year and Ecosystem Vendor of the Year.

Dan Scott, Quality and Implementation Manager, Complete I.T. Ltd, attended last year's IT Nation Europe conference and said he considers it the "must see" event of the year. "The value I gained from a unique combination of valuable educational content, sponsors and, most importantly, networking with a community of industry peers who all contribute, share and inspire in equal measure was immeasurable," he said.

This year's event will be held at the Hilton London Metropole. To learn more about IT Nation Europe and register, visit the ConnectWise IT Nation Europe website.  

Follow ConnectWise  
LinkedIn
ConnectWise Blog
Twitter
Facebook
YouTube

About ConnectWise
ConnectWise transforms how technology solution providers successfully build, manage and grow their businesses. Our award-winning set of software solutions provides a fully integrated, seamless experience to companies in more than 50 countries, giving them the ability to increase their productivity, efficiency and profitability. When combined with our relentless commitment to innovation, powerful network of ideas and experts, unparalleled passion for our users, and more than 35 years of experience, ConnectWise software solutions deliver the support companies want at each step of their business journey. For more information, visit www.ConnectWise.com.

Press Contacts
Elizabeth Bassler
EBassler@ConnectWise.com

Diane Rose for ConnectWise
diane@dkrcomms.com

A photo accompanying this announcement is available at http://www.globenewswire.com/NewsRoom/AttachmentNg/75f7aada-20c1-4ee4-9b94-58ea8a896e0b




This announcement is distributed by Nasdaq Corporate Solutions on behalf of Nasdaq Corporate Solutions clients.
The issuer of this announcement warrants that they are solely responsible for the content, accuracy and originality of the information contained therein.
Source: ConnectWise via Globenewswire

Om

GlobeNewswire



Följ GlobeNewswire

Abonnera på våra pressmeddelanden.

Senaste pressmeddelandena från GlobeNewswire

Karolinska Development's portfolio company Modus Therapeutics completes enrollment in Phase II study with sevuparin7.1.2019 12:00Pressmeddelande

STOCKHOLM, January 7, 2019. Karolinska Development's portfolio company Modus Therapeutics announces that the patient enrollment has been completed in the Phase II study with sevuparin in patients with sickle cell disease (SCD). The results from the study is expected in mid 2019. Modus Therapeutic's randomized, double blind study contains 140 SCD-patients with Acute Vaso Occlusive Crisis (VOC). It compares intravenously administered sevuparin with placebo. The primary endpoint of the study is the demonstration of a reduced time to resolution of patient's VOC. Clincal sites across Europe and the Middle East took part in the study that was conducted in conjunction with Modus Therapeutics' co development partner Ergomed. SCD has a high unmet medical need as there are currently no approved therapies for VOCs. It is an inherited blood disorder that affects between 90,000 to 100,000 patients in the U.S. and is characterized by severely painful VOCs that lead to organ damage due to a lack of o

Karolinska Development's portfolio company Modus Therapeutics completes enrollment in Phase II study with sevuparin7.1.2019 12:00Pressmeddelande

STOCKHOLM, January 7, 2019. Karolinska Development's portfolio company Modus Therapeutics announces that the patient enrollment has been completed in the Phase II study with sevuparin in patients with sickle cell disease (SCD). The results from the study is expected in mid 2019. Modus Therapeutic's randomized, double blind study contains 140 SCD-patients with Acute Vaso Occlusive Crisis (VOC). It compares intravenously administered sevuparin with placebo. The primary endpoint of the study is the demonstration of a reduced time to resolution of patient's VOC. Clincal sites across Europe and the Middle East took part in the study that was conducted in conjunction with Modus Therapeutics' co development partner Ergomed. SCD has a high unmet medical need as there are currently no approved therapies for VOCs. It is an inherited blood disorder that affects between 90,000 to 100,000 patients in the U.S. and is characterized by severely painful VOCs that lead to organ damage due to a lack of o

Stillfront Group rekryterar ansvarig för M&A19.12.2018 12:07Pressmeddelande

PRESSMEDDELANDE 19 december, 2018 Stillfront Group rekryterar ansvarig för M&A Stillfront Group, en marknadsledare inom 'free to play' online strategispel, annonserar idag att Marina Andersson har utsetts till ansvarig för M&A och kommer att ingå i koncernledningen. Marina har närmare tjugo års erfarenhet från investment banking och M&A. Hon har omfattande erfarenhet inom strategisk och finansiell rådgivning, affärsgenerering, projektledning inom förvärv och försäljningar av företag, finansiell analys, due diligence, samt företagsvärdering. Tidigare positioner inkluderar: Director, Deloitte's Corporate Finance Advisory team, Director, ICECAPITAL Securities, Associate Partner och Investment Manager, Deseven, samt M&A Analytiker på Carnegie. Marina har två magister-examen från Stockholms universitet och Russian Herzen State Pedagogical University. "Förvärv är en viktig del av Stillfronts affärsstrategi och vi är mycket glada att rekrytera Marina Andersson. Marinas breda erfarenhet och pr

Stillfront Group announces Head of M&A19.12.2018 12:07Pressmeddelande

PRESS RELEASE December 19, 2018 Stillfront Group announces Head of M&A Stillfront Group, a market leader in 'free to play' online strategy games, today announces that Marina Andersson has been appointed as Head of M&A and will be part of the Group's management team. Marina has close to 20 years track record of investment banking and M&A. She has extensive competence within strategic and financial advisory, deal generation, buy and sell side M&A project management, financial analysis, due diligence and company valuation. Former positions include: Director at Deloitte's Corporate Finance Advisory team, Director at ICECAPITAL Securities, Associate Partner and Investment Manager at Deseven, M&A Analyst at Carnegie. She holds two Master degrees from Stockholm University and Russian Herzen State Pedagogical University. "Acquisitions are a crucial part of Stillfront's business strategy and we are very pleased with the appointment of Marina Andersson. Marina's breadth of experience and profess

Oboya tecknar ett samarbetsavtal med Gaia avseende biomaterial13.12.2018 11:41Pressmeddelande

Oboya Horticulture Industries AB (publ) ("Oboya") har tecknat ett viktigt och långsiktigt samarbetsavtal avseende miljövänligt biomaterial med Gaia Biomaterials AB ("Gaia") i Helsingborg, Sverige. Avtalet innebär att Oboya använder Gaias biomaterial för tillverkning och utveckling av miljövänliga odlingsprodukter till odlingsindustrin. Oboya har under de senaste åren arbetat aktivt med innovation, miljö- och hållbarhetsfrågor och vårt mål är att främja miljö och hållbarhet inom odlingsindustrin genom att erbjuda miljövänliga odlingsprodukter till våra kunder. Oboya anser att användningen av biomaterial kommer att vara viktigt för framgång i omställningen till en fossilfri odlingsindustri världen över. Samarbetsavtalet innebär att Oboya använder Gaias biomaterial i sin produktion och att vi genom Gaias kompetens kan utveckla nya miljövänliga odlingsprodukter. Gaias biomaterial är biologiskt nedbrytbart, komposterbart samt ger upp till 80 % lägre koldioxidutsläpp vid förbränning jämfört

Oboya signs a cooperation agreement with Gaia regarding biomaterials13.12.2018 11:41Pressmeddelande

Oboya Horticulture Industries AB (publ) ("Oboya") has signed an important and long-term cooperation agreement on environmentally friendly biomaterials with Gaia Biomaterials AB ("Gaia") in Helsingborg, Sweden. The agreement means that Oboya uses Gaias biomaterials for the production and development of environmentally friendly cultivation products for the cultivation industry. Oboya has been actively involved in innovation, environmental and sustainability issues in recent years, and our goal is to encourage environmental and sustainability in the cultivation industry by offering environmentally friendly cultivation products to our customers. Oboya believes that the use of biomaterials will be important for success in the conversion to a fossil-free cultivation industry worldwide. The cooperation agreement means that Oboya uses Gaias biomaterials in its production and that through Gaias expertise we can develop new environmentally friendly cultivation products. Gaias biomaterials are bi

I vårt pressrum kan du läsa de senaste pressmeddelandena, få tillgång till pressmaterial och hitta kontaktinformation.

Besök vårt pressrum